title: Classification, epidemiology and therapies for testicular germ cell tumours.
abstract: Testicular germ cell tumours (TGCT) account for between 1% and 1.5% of male neoplasms and 5% of urological tumours in general. They are classified broadly into Seminoma, which resemble primordial germ cells (PGCs), and Non-Seminoma, which are either undifferentiated (embryonal carcinoma) or differentiated (exhibiting a degree of embryonic (teratoma) or extra-embryonic (yolk sac choriocarcinoma) patterning). We present the current details of the latest classification, epidemiology and treatment aspects of TGCT in the UK in our review.
authors.affiliation: Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom. nikhilvasdev@doctors.org.uk
authors.forename: Nikhil
authors.initials: N
authors.lastname: Vasdev
authors.forename: Andrew
authors.initials: A
authors.lastname: Moon
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Thorpe
mesh_terms: D000818:Animals; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000145:classification / Q000453:epidemiology* / Q000628:therapy*; D013736:Testicular Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000628:therapy*